Login
$IGC
$0.25 -$0.00 (0.8%) Close

Company Executives

Officer Age In this role Joined Pay Source
Ram Mukunda Also a director
President, Chief Executive Officer, and Director
68 Not stated Not stated Not reported
Claudia Grimaldi Also a director
Vice President, Principal Financial Officer, Chief Compliance Officer, and Director
55 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
5
serving now
Independent
3 of 3
stated in the proxy; 2 not stated
Average tenure
10.0 years
from year joined
CEO also chairs the board
No
Richard Prins
Director Age On board Independent Committees Other public boards Pay Source
Richard Prins
69 2007
19 years
Independent
Audit Committee · Chair Compensation Committee · Chair
Amphastar Pharmaceuticals, Inc. Not stated
Ram Mukunda
68 2005
21 years
Not stated None stated None stated Paid as CEO
Claudia Grimaldi
55 2022
4 years
Not stated None stated None stated Not stated
James Moran
81 2022
4 years
Independent
Audit Committee Compensation Committee
None stated Not stated
Terry L. Lierman
78 2024
2 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

4 disclosed in the proxy filed Oct 22, 2026
Ms. Claudia Grimaldi
the Company’s Principal Financial Officer
Approximately $146 thousand
nine months ended December 31, 2025

Working capital loan received by the Company from Ms. Grimaldi, bearing interest at the U.S. federal funds rate plus 5.0%, with principal due on demand.

Mr. Ram Mukunda
the Company’s President and Chief Executive Officer
Approximately $601,148

Stock Purchase Agreement to issue 2,226,475 shares of Common Stock at $0.27 per share in satisfaction of obligations owed to him, including personal cash advances.

Ms. Claudia Grimaldi
the Company’s Vice President and Principal Financial Officer
Amount not stated

Stock Purchase Agreement to issue 2,048,378 shares of Common Stock at $0.27 per share in satisfaction of obligations owed to her, including personal cash advances.

Mr. James Moran
owns Moran Global Strategies, Inc., an independent director of the Company
Aggregate consideration of $200,000

Share Purchase Agreement for the sale by the Company of 588,235 shares of common stock at $0.34 per share.

With Moran Global Strategies, Inc. (MGS) Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support